Rua Bioscience Ltd
NZX:RUA

Watchlist Manager
Rua Bioscience Ltd Logo
Rua Bioscience Ltd
NZX:RUA
Watchlist
Price: 0.03 NZD Market Closed
Market Cap: 8.6m NZD
Have any thoughts about
Rua Bioscience Ltd?
Write Note

Rua Bioscience Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rua Bioscience Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Rua Bioscience Ltd
NZX:RUA
Income from Continuing Operations
-NZ$13.7m
CAGR 3-Years
-46%
CAGR 5-Years
-47%
CAGR 10-Years
N/A
BLIS Technologies Ltd
NZX:BLT
Income from Continuing Operations
NZ$646k
CAGR 3-Years
5%
CAGR 5-Years
11%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Income from Continuing Operations
NZ$11.3m
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Income from Continuing Operations
-NZ$8.8m
CAGR 3-Years
-36%
CAGR 5-Years
-105%
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Income from Continuing Operations
-NZ$1.6m
CAGR 3-Years
-8%
CAGR 5-Years
-83%
CAGR 10-Years
N/A
No Stocks Found

Rua Bioscience Ltd
Glance View

Market Cap
8.6m NZD
Industry
Pharmaceuticals

Rua Bioscience Ltd. operates as a pharmaceutical company that develops medical cannabis products. The company is headquartered in Gisborne, Gisborne. The company went IPO on 2020-10-22. The firm operate in the medicinal cannabis sector commercially and is focused on producing cannabinoid derived medicines. The firm is also focusing on cultivating and developing quality-assured medicinal cannabis as active pharmaceutical ingredients.

RUA Intrinsic Value
0.001 NZD
Overvaluation 96%
Intrinsic Value
Price

See Also

What is Rua Bioscience Ltd's Income from Continuing Operations?
Income from Continuing Operations
-13.7m NZD

Based on the financial report for Jun 30, 2024, Rua Bioscience Ltd's Income from Continuing Operations amounts to -13.7m NZD.

What is Rua Bioscience Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-47%

Over the last year, the Income from Continuing Operations growth was -130%. The average annual Income from Continuing Operations growth rates for Rua Bioscience Ltd have been -46% over the past three years , -47% over the past five years .

Back to Top